No evidence of human papillomavirus DNA in breast carcinoma in Tunisian patients

Breast

Volumn 19, Issue 6, 2010, Pages 541-544

  Hachana, Mohamed ^a   Ziadi, Sonia ^a   Amara, Khaled ^a   Toumi, Intissar ^a   Korbi, Sadok ^a   Trimeche, Mounir ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Breast cancer; Human papillomaviruses; Tunisia

Indexed keywords

CAPSID PROTEIN L1; GLYCOPROTEIN E1; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ADULT; AGED; ARTICLE; BIOTINYLATION; BREAST CARCINOMA; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DNA PROBE; FEMALE; GENE AMPLIFICATION; GENOMIC IN SITU HYBRIDIZATION; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; INFECTION RISK; MAJOR CLINICAL STUDY; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUNISIA; VIRUS DETECTION;

EID: 78349305198     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.05.007     Document Type: Article

References (44)

1. Ferlay J., Bray F., Pisani P., Parkin D.M. Globocan 2002 cancer incidence, mortality and prevalence Worldwide IARC CancerBase No. 5, version 2.0 2004, IARC Press, Lyon.
2. Wazer D.E., Liu X.L., Chu Q., Gao Q., Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A 1995, 92:3687-3691.
3. Di Lonardo A., Venuti A., Marcante M.L. Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992, 21:95-100.
4. Yu Y., Morimoto T., Sasa M., Okazaki K., Harada Y., Fujiwara T., et al. Human papillomavirus type 33 DNA in breast cancer in chinese. Breast Cancer 2000, 7:33-36.
5. Liu Y., Klimberg V.S., Andrews N.R., Hicks C.R., Peng H., Chiriva-Internati M., et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 2001, 4:329-334.
6. Li T., Lu Z.M., Guo M., Wu Q.J., Chen K.N., Xing H.P., et al. P53 codon 72 polymorphism (c/g) and the risk of human papillomavirus-associated carcinomas in china. Cancer 2002, 95:2571-2576.
7. Damin A.P., Karam R., Zettler C.G., Caleffi M., Alexandre C.O. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 2004, 84:131-137.
8. Widschwendter A., Brunhuber T., Wiedemair A., Mueller-Holzner E., Marth C. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 2004, 31:292-297.
9. Kan C.Y., Iacopetta B.J., Lawson J.S., Whitaker N.J. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 2005, 93:946-948.
10. de Villiers E.M., Sandstrom R.E., zur Hausen H., Buck C.E. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005, 7:R1-R11.
11. Kroupis C., Markou A., Vourlidis N., Dionyssiou-Asteriou A., Lianidou E.S. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006, 39:727-731.
12. Choi Y.L., Cho E.Y., Kim J.H., Nam S.J., Oh Y.L., Song S.Y., et al. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of korean women. Tumour Biol 2007, 28:327-332.
13. Khan N.A., Castillo A., Koriyama C., Kijima Y., Umekita Y., Ohi Y., et al. Human papillomavirus detected in female breast carcinomas in japan. Br J Cancer 2008, 99:408-414.
14. Akil N., Yasmeen A., Kassab A., Ghabreau L., Darnel A.D., Al Moustafa A.E. High-risk human papillomavirus infections in breast cancer in syrian women and their association with id-1 expression: a tissue microarray study. Br J Cancer 2008, 99:404-407.
15. Mendizabal-Ruiz A.P., Morales J.A., Ramirez-Jirano L.J., Padilla-Rosas M., Moran-Moguel M.C., Montoya-Fuentes H. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 2009, 114:189-194.
16. Cantu de Leon D., Perez Montiel D., Nemcova J., Mikyskova I., Turcios E., Villavicencio V., et al. Human papillomavirus (hpv) in breast tumors: prevalence in a group of mexican patients. BMC Cancer 2009, 9:26.
17. Tsai J.H., Tsai C.H., Cheng M.H., Lin S.J., Xu F.L., Yang C.C. Association of viral factors with non-familial breast cancer in taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 2005, 75:276-281.
18. Wrede D., Luqmani Y.A., Coombes R.C., Vousden K.H. Absence of hpv 16 and 18 DNA in breast cancer. Br J Cancer 1992, 65:891-894.
19. Gopalkrishna V., Singh U.R., Sodhani P., Sharma J.K., Hedau S.T., Mandal A.K., et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 1996, 39:197-202.
20. Bratthauer G.L., Tavassoli F.A., O'Leary T.J. Etiology of breast carcinoma. No apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract 1992, 188:384-386.
21. Lindel K., Forster A., Altermatt H.J., Greiner R., Gruber G. Breast cancer and human papillomavirus (hpv) infection: no evidence of a viral etiology in a group of swiss women. Breast 2007, 16:172-177.
22. de Cremoux P., Thioux M., Lebigot I., Sigal-Zafrani B., Salmon R., Sastre-Garau X. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008, 109:55-58.
23. Czerwenka K., Heuss F., Hosmann J.W., Manavi M., Lu Y., Jelincic D., et al. Human papilloma virus DNA: a factor in the pathogenesis of mammary paget's disease?. Breast Cancer Res Treat 1996, 41:51-57.
24. Tavassoli F.A., Devilee P. Pathology and genetics of tumors of the breast and female genital organs, WHO classification of tumors 2003, IARC Press.
25. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
26. Hachana M., Trimeche M., Ziadi S., Amara K., Korbi S. Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Res Treat 2009, 113:43-58.
27. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986, 324:163-166.
28. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J. The use of general primers gp5 and gp6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by pcr. J Gen Virol 1995, 76(Pt 4):1057-1062.
29. Josefsson A., Livak K., Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J Clin Microbiol 1999, 37:490-496.
30. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I. Fujinaga K:.Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991, 72(Pt 5):1039-1044.
31. Baay M.F., Quint W.G., Koudstaal J., Hollema H., Duk J.M., Burger M.P., et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by pcr in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996, 34:745-747.
32. McGlennen R.C. Human papillomavirus oncogenesis. Clin Lab Med 2000, 20:383-406.
33. Bergeron C., Barrasso R., Beaudenon S., Flamant P., Croissant O., Orth G. Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol 1992, 16:641-649.
34. Brestovac B., Harnett G.B., Smith D.W., Shellam G.R., Frost F.A. Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of western australian women. J Med Virol 2005, 76:106-110.
35. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of hpv type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003, 89:101-105.
36. Missaoui N., Hmissa S., Frappart L., Trabelsi A., Ben Abdelkader A., Traore C., et al. P16ink4a overexpression and hpv infection in uterine cervix adenocarcinoma. Virchows Arch 2006, 448:597-603.
37. Hassen E., Chaieb A., Letaief M., Khairi H., Zakhama A., Remadi S., et al. Cervical human papillomavirus infection in tunisian women. Infection 2003, 31:143-148.
38. De Marco F., Houissa-Kchouk F., Khelifa R., Marcante M.L. High-risk hpv types in tunisia. A pilot study reveals an unexpectedly high prevalence of types 58 and 82 and lack of hpv 18 among female prostitutes. J Med Virol 2006, 78:950-953.
39. Hennig E.M., Suo Z., Thoresen S., Holm R., Kvinnsland S., Nesland J.M. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (cin iii). Breast Cancer Res Treat 1999, 53:121-135.
40. Gumus M., Yumuk P.F., Salepci T., Aliustaoglu M., Dane F., Ekenel M., et al. Hpv DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res 2006, 25:515-521.
41. Aguayo F., Castillo A., Koriyama C., Higashi M., Itoh T., Capetillo M., et al. Human papillomavirus-16 is integrated in lung carcinomas: a study in chile. Br J Cancer 2007, 97:85-91.
42. Shuyama K., Castillo A., Aguayo F., Sun Q., Khan N., Koriyama C., et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in china. Br J Cancer 2007, 96:1554-1559.
43. Koskinen W.J., Chen R.W., Leivo I., Makitie A., Back L., Kontio R., et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003, 107:401-406.
44. Drain P.K., Holmes K.K., Hughes J.P., Koutsky L.A. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002, 100:199-205.